vs
Side-by-side financial comparison of Beeline Holdings, Inc. (BLNE) and Insight Molecular Diagnostics Inc. (IMDX). Click either name above to swap in a different company.
Beeline Holdings, Inc. is the larger business by last-quarter revenue ($1.9M vs $1.1M, roughly 1.6× Insight Molecular Diagnostics Inc.). Beeline Holdings, Inc. runs the higher net margin — -445.0% vs -2015.4%, a 1570.4% gap on every dollar of revenue. Insight Molecular Diagnostics Inc. produced more free cash flow last quarter ($-7.0M vs $-21.5M). Over the past eight quarters, Insight Molecular Diagnostics Inc.'s revenue compounded faster (154.4% CAGR vs -33.0%).
Beeline or билайн is a mobile network operator brand operating in Russia under PJSC VimpelCom, and in Kazakhstan, Kyrgyzstan and Uzbekistan under VEON Ltd. Beeline is Russia's fourth-largest mobile network operator, and main competitors being MTS, MegaFon and T2.
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
BLNE vs IMDX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.9M | $1.1M |
| Net Profit | $-8.4M | $-23.0M |
| Gross Margin | — | 42.5% |
| Operating Margin | -418.4% | -2057.5% |
| Net Margin | -445.0% | -2015.4% |
| Revenue YoY | — | -23.4% |
| Net Profit YoY | -16.1% | 31.5% |
| EPS (diluted) | — | $-0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.9M | $1.1M | ||
| Q3 25 | $2.3M | $260.0K | ||
| Q2 25 | $1.7M | $518.0K | ||
| Q1 25 | $1.8M | $2.1M | ||
| Q4 24 | — | $1.5M | ||
| Q3 24 | $783.0K | $115.0K | ||
| Q2 24 | $3.1M | $104.0K | ||
| Q1 24 | $2.5M | $176.0K |
| Q4 25 | $-8.4M | $-23.0M | ||
| Q3 25 | $-3.9M | $-10.9M | ||
| Q2 25 | $-4.1M | $-9.7M | ||
| Q1 25 | $-6.8M | $-6.7M | ||
| Q4 24 | — | $-33.5M | ||
| Q3 24 | $-1.4M | $-13.5M | ||
| Q2 24 | $-1.5M | $-4.5M | ||
| Q1 24 | $-1.3M | $-9.1M |
| Q4 25 | — | 42.5% | ||
| Q3 25 | — | 53.5% | ||
| Q2 25 | — | 67.6% | ||
| Q1 25 | — | 62.0% | ||
| Q4 24 | — | 40.0% | ||
| Q3 24 | 25.5% | 43.5% | ||
| Q2 24 | 5.0% | 48.1% | ||
| Q1 24 | 7.5% | 25.6% |
| Q4 25 | -418.4% | -2057.5% | ||
| Q3 25 | -120.9% | -4249.2% | ||
| Q2 25 | -229.0% | -1900.0% | ||
| Q1 25 | -268.7% | -318.0% | ||
| Q4 24 | — | -2262.9% | ||
| Q3 24 | -55.6% | -11752.2% | ||
| Q2 24 | -11.4% | -4453.8% | ||
| Q1 24 | -18.5% | -5265.3% |
| Q4 25 | -445.0% | -2015.4% | ||
| Q3 25 | -167.2% | -4174.6% | ||
| Q2 25 | -237.3% | -1880.7% | ||
| Q1 25 | -372.4% | -312.0% | ||
| Q4 24 | — | -2255.1% | ||
| Q3 24 | -173.6% | -11733.0% | ||
| Q2 24 | -48.6% | -4355.8% | ||
| Q1 24 | -52.0% | -5186.9% |
| Q4 25 | — | $-0.75 | ||
| Q3 25 | $-0.20 | $-0.34 | ||
| Q2 25 | $-0.64 | $-0.30 | ||
| Q1 25 | — | $-0.26 | ||
| Q4 24 | — | $-2.19 | ||
| Q3 24 | $-6.60 | $-0.98 | ||
| Q2 24 | $-8.74 | $-0.36 | ||
| Q1 24 | $-0.78 | $-1.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.1M | $11.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $53.6M | $-31.5M |
| Total Assets | $70.2M | $25.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.1M | $11.6M | ||
| Q3 25 | $1.3M | $18.7M | ||
| Q2 25 | $6.3M | $24.3M | ||
| Q1 25 | $1.5M | $31.0M | ||
| Q4 24 | — | $8.6M | ||
| Q3 24 | $310.0K | $3.4M | ||
| Q2 24 | $420.0K | $9.3M | ||
| Q1 24 | $147.0K | $5.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $8.2M | — | ||
| Q2 24 | $8.1M | — | ||
| Q1 24 | $8.1M | — |
| Q4 25 | $53.6M | $-31.5M | ||
| Q3 25 | $51.7M | $-9.2M | ||
| Q2 25 | $54.6M | $1.1M | ||
| Q1 25 | $47.1M | $10.2M | ||
| Q4 24 | — | $-12.3M | ||
| Q3 24 | $-2.5M | $9.7M | ||
| Q2 24 | $-1.9M | $22.7M | ||
| Q1 24 | $-476.0K | $11.6M |
| Q4 25 | $70.2M | $25.8M | ||
| Q3 25 | $63.2M | $43.9M | ||
| Q2 25 | $68.6M | $50.5M | ||
| Q1 25 | $63.8M | $60.4M | ||
| Q4 24 | — | $35.1M | ||
| Q3 24 | $16.2M | $70.2M | ||
| Q2 24 | $16.6M | $74.7M | ||
| Q1 24 | $17.0M | $71.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-21.4M | $-5.5M |
| Free Cash FlowOCF − Capex | $-21.5M | $-7.0M |
| FCF MarginFCF / Revenue | -1143.3% | -616.7% |
| Capex IntensityCapex / Revenue | 0.8% | 129.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-25.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-21.4M | $-5.5M | ||
| Q3 25 | $-5.8M | $-4.5M | ||
| Q2 25 | $-4.1M | $-6.3M | ||
| Q1 25 | $-1.5M | $-5.9M | ||
| Q4 24 | — | $-5.4M | ||
| Q3 24 | $-652.0K | $-5.5M | ||
| Q2 24 | $-872.0K | $-6.0M | ||
| Q1 24 | $-82.0K | $-3.8M |
| Q4 25 | $-21.5M | $-7.0M | ||
| Q3 25 | — | $-5.6M | ||
| Q2 25 | — | $-6.6M | ||
| Q1 25 | — | $-6.2M | ||
| Q4 24 | — | $-5.6M | ||
| Q3 24 | — | $-5.6M | ||
| Q2 24 | — | $-6.2M | ||
| Q1 24 | — | $-3.9M |
| Q4 25 | -1143.3% | -616.7% | ||
| Q3 25 | — | -2135.4% | ||
| Q2 25 | — | -1279.5% | ||
| Q1 25 | — | -288.4% | ||
| Q4 24 | — | -374.5% | ||
| Q3 24 | — | -4884.3% | ||
| Q2 24 | — | -5931.7% | ||
| Q1 24 | — | -2189.8% |
| Q4 25 | 0.8% | 129.9% | ||
| Q3 25 | — | 403.8% | ||
| Q2 25 | — | 67.4% | ||
| Q1 25 | — | 14.4% | ||
| Q4 24 | — | 14.4% | ||
| Q3 24 | — | 75.7% | ||
| Q2 24 | — | 183.7% | ||
| Q1 24 | — | 13.6% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLNE
| Beeline Title Holdings | $1.4M | 73% |
| Other | $498.0K | 27% |
IMDX
Segment breakdown not available.
